<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Moderna stock gained almost 6% over the last week (five trading days) outperforming the broader S&P 500 which was up about 2% over the same period. The recent gains come amid some upgrades on the stock by brokerage analysts and also by the U.S. FDA vaccines advisory committee’s unanimous vote in.
...read full article on Forbes
